They're asking the FDA to declare the pill used in about 40% of abortions an “imminent hazard to public health.”
By Carter Sherman
September 2, 2020
Sen. Ted Cruz is leading the charge on a Hail Mary plea to the Food and Drug and Administration: He wants the agency to cut off access to a pill that’s used in nearly 40% of U.S. abortions.
On Monday, the Texas Republican led a group of 20 senators in sending a letter to the commissioner of the FDA, asking the agency to take the pill mifepristone, which helps induce abortions, off the U.S. market. The senators want the pill declared an “imminent hazard to public health.”
August 16, 2020
The FDA is being urged to let women obtain abortion-inducing drugs by means of the mail amid the coronavirus slightly than have to go away their houses to get them.
“Whereas any girl who desires to go into a health care provider’s workplace or right into a clinic at the moment and get an abortion ought to proceed to have the opportunity to achieve this, management over one’s reproductive freedom shouldn’t be restricted to these ready to go away their houses as we battle the coronavirus,” New York Lawyer Normal Letitia James mentioned in an announcement Monday — echoing a letter despatched by her and 20 different high law-enforcement officers to the FDA urging an easing-up of restrictions.
Easy Access to Abortion Pill Vital During Pandemic, FDA Told
June 16, 2020
The FDA should relax restrictions on a medication used for abortion during the pandemic to prevent unnecessary travel, over 100 members of the House said Tuesday in a letter to the agency.
Under the current rules, a person who wants to use mifepristone to help terminate a pregnancy must get it directly from their health-care provider. Mifepristone—which blocks progesterone and stops a pregnancy from advancing—is typically used in combination with a second pill, misoprostol—which causes cramping and bleeding that empties the uterus—when used to terminate a pregnancy. Misoprostol is available at pharmacies with a prescription.
No-Test Medication Abortion Increases Safety and Access During COVID-19
A new study proposes an innovative, no-test medication abortion protocol that would enable clinicians to safely administer medication abortion to patients without any preliminary tests or in-person encounters
by Carrie N. Baker
Imagine a world where women could access safe and supported abortion health care without ever leaving their homes. In this world, after a phone call or video conference with a health care professional, women could receive the abortion pill in the mail, which they could take safely in the privacy of their own homes under the supervision of a clinician.
No invasive, time-consuming pelvic exams or blood tests. No state-mandated ultrasounds or waiting periods requiring multiple visits. No walking past lines of screaming anti-abortion protesters. No driving long distances, having to find and pay for child care, or taking time off from work. No exposure to COVID-19.
Amid Covid-19, a Call for M.D.s to Mail the Abortion Pill
For decades, the consensus has been that F.D.A. regulations require that the abortion pill be obtained in a clinic. But that’s changing.
By Patrick Adams
May 12, 2020
Last fall, months before America’s first outbreak of the coronavirus, Francine Coeytaux and Elisa Wells, co-founders of the abortion rights advocacy group Plan C, were reaching out to doctors with a question they said was urgent:
“Would you be willing to mail the ‘abortion pills’ to women in their homes?”
The UK allows home use of the abortion pill — the US should do the same
By Susan F. Wood and Cynthia Pearson, opinion contributors
In late March, the United Kingdom issued new guidance authorizing physicians to provide medication abortion pills to those wishing to end their pregnancies during the COVID-19 pandemic. The change was immediately embraced by the public and by British abortion providers who know home use is a safe and effective way to experience an early abortion.
British patients who need an early abortion now consult with a provider by telephone or video link and the medication abortion pills are then delivered to the patient’s home. This is a safe, sensible way to protect pregnant women and their doctors during an epidemic. British leaders and medical experts are to be commended for recognizing that abortion is an essential health care service that can be provided safely within the constraints of physical distancing and stay-at-home orders.
FDA Should Lift Abortion Pill Restrictions, Says Former Agency Head
Jane Henney says the restrictions are dangerous during a pandemic because they require unnecessary travel and contact between patients and providers.
by Marie Solis
Apr 27 2020
For two decades, the Food and Drug Administration has maintained restrictions on the abortion drug mifepristone that require patients to receive it from a licensed provider at a hospital or clinic, despite overwhelming evidence that shows the drug is safe and effective to take outside of immediate medical supervision. For patients, that has meant that instead of filling a prescription at the pharmacy—as we do with countless other medications—they must face all the obstacles to accessing abortion clinics, which dwindle in number every year, just to be handed a pill.
Self-Managed Abortions May Be More Difficult to Access Right Now—Here’s What You Need to Know
With supply chain disruptions in India due to the global COVID-19 pandemic, medication abortion may be less accessible—an issue compounded by anti-choice state officials trying to ban the procedure and the FDA.
Apr 14, 2020
If you visit aidaccess.org in search of the abortion pill right now, you won’t be able to find what they’re looking for. Aid Access, a website that offers medication abortion pills by mail for people in the United States seeking to self-manage their abortion, has hit a snag in its supply chain, thanks to a halt in trade out of India because of the coronavirus outbreak.
“Because of [COVID-19] the government of India have decided to close all international airports to prevent corona virus outbreak and therefor [sic] the pharmacy in India cannot send the medicines until further notice,” reads a disclosure on the Aid Access website’s consultation page.
FDA urged to let women get abortion drugs by mail during coronavirus crisis
By Kate Sheehy
March 30, 2020
The FDA is being urged to let women receive abortion-inducing drugs through the mail amid the coronavirus rather than have to leave their homes to get them.
“While any woman who wants to go into a doctor’s office or into a clinic today and get an abortion should continue to be able to do so, control over one’s reproductive freedom should not be limited to those able to leave their homes as we battle the coronavirus,” New York Attorney General Letitia James said in a statement Monday — echoing a letter sent by her and 20 other top law-enforcement officials to the FDA urging an easing-up of restrictions.
2020 Dems Say They'll Protect Abortion Access. We Asked Them About Pills
We asked every Democrat who qualified for the debate about expanding access to medication abortion.
by Marie Solis; illustrated by Hunter French
Dec 16 2019
The October and November debates finally saw Democratic presidential candidates answer questions about abortion from moderators, months after reproductive health organizations and pro-choice advocates launched a pressure campaign to get 2020 contenders to talk about the issue on primetime television.
So far, candidates' plans for protecting abortion rights have consisted primarily of pledges to codify Roe v. Wade, which would require pro-choice majorities in the House and Senate to pass federal legislation upholding the principles of Roe in the event that the Supreme Court overturns or guts the 1973 decision.